Apollomics Inc. (APLMW) SEC Filings — 2025
14 SEC filings for Apollomics Inc. (APLMW) in 2025.
Filings
- Apollomics Inc. Files 6-K with Mid-Year Financials — 6-K · Dec 22, 2025
- Apollomics Inc. 6-K Filing — 6-K · Dec 12, 2025
- Apollomics Inc. 6-K Filing — 6-K · Nov 19, 2025
- Apollomics Inc. 6-K Filing — 6-K · Nov 18, 2025
- Apollomics: LaunXP Payment Still Pending — 6-K · Oct 21, 2025
- Apollomics Inc. Changes Auditors — 6-K · Oct 16, 2025
- Apollomics Inc. Updates Operations, Focuses on Oncology Pipeline — 6-K · Oct 14, 2025
- Apollomics Faces Nasdaq Delisting — 6-K · Sep 25, 2025
- Apollomics Appoints Two New Directors to Board — 6-K · Sep 5, 2025
- Apollomics Closes Private Placement — 6-K · Sep 3, 2025
- Apollomics Terminates US Staff, Halts SPARTA Trial — 6-K · Aug 28, 2025
- Apollomics Licenses Vebreltinib Rights in Asia — 6-K · Jul 25, 2025
- Apollomics Inc. 20-F Filing — 20-F · Apr 3, 2025
- Apollomics inks Asia deal for NSCLC drug vebreltinib — 6-K · Mar 31, 2025